Clinical-Biochemical Correlations in Acromegaly at Diagnosis and the Real Prevalence of Biochemically Discordant Disease
- 1 December 2004
- journal article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 62 (6), 293-299
- https://doi.org/10.1159/000082032
Abstract
To analyze clinical-biochemical correlations in newly diagnosed acromegaly, focusing in particular on patients with discrepant parameters. Retrospective study. Data from 164 patients with acromegaly seen between 1995 and 2003. Patients were reviewed for the presence of headaches, arthralgias, hypertension, menstrual abnormalities, impotence, glucose intolerance or diabetes. Biochemical evaluation consisted of age- and gender-adjusted IGF-I levels and glucose-suppressed GH. Magnetic resonance imaging (MRI) revealed macroadenoma in 127 patients and microadenoma in 37. Patients with macroadenomas were younger than those with microadenomas and the disease was more frequent in females. Excluding acral enlargement, which was present in all the patients, the most commonly reported complaints were headaches (66%) and arthralgias (52%). Hypertension was present in 37% of patients, whereas the prevalence of glucose intolerance and diabetes was 27 and 32%, respectively. Hyperprolactinemia was present in 20% of patients with microadenomas and in 40% of patients with macroadenomas. Hypogonadism was demonstrated in more than half of the patients and was not related to tumor size or prolactin level. Of all the clinical and metabolic abnormalities of acromegaly, only the presence of diabetes correlated with both basal and nadir post-glucose GH levels. Only 4 patients (2.4%) had glucose-suppressed GH values of <1 ng/ml in the presence of clinical evidence of acromegaly, an elevated IGF-I level and a pituitary adenoma on MRI. Clinical features of acromegaly correlate poorly with indices of biochemical activity. The prevalence of biochemically discordant acromegaly is considerably lower than recently reported.Keywords
This publication has 13 references indexed in Scilit:
- Short-Term Suppression of GH and IGF-I Levels Improves Gonadal Function and Sperm Parameters in Men with AcromegalyJournal of Clinical Endocrinology & Metabolism, 2002
- Acromegaly with Apparently Normal GH Secretion: Implications for Diagnosis and Follow-UpJournal of Clinical Endocrinology & Metabolism, 2002
- Assessment of Disease Activity in Treated Acromegalic Patients Using a Sensitive GH Assay: Should We Achieve Strict Normal GH Levels for a Biochemical Cure?Journal of Clinical Endocrinology & Metabolism, 2002
- Therapy of diabetes and dyslipidemia in acromegaly.Pituitary, 2002
- Insulin-like growth factor 1 measurement in diagnosis and management of acromegalyAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2001
- Relationship between blood pressure and glucose tolerance in acromegalyClinical Endocrinology, 2001
- Pathogenesis and Prevalence of Hypertension in AcromegalyPituitary, 2001
- Evaluation of Disease Status with Sensitive Measures of Growth Hormone Secretion in 60 Postoperative Patients with AcromegalyJournal of Clinical Endocrinology & Metabolism, 1998
- Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than womenJournal of Clinical Endocrinology & Metabolism, 1994
- Acromegaly: An epidemiological studyJournal of Endocrinological Investigation, 1993